Last year, 2019, was a good news-bad news year for polio eradication efforts. What’s good and bad depends on whether you are a human or the polio virus.
While I expect the status quo to continue in 2020 regarding drug price reform, as the end of the year approaches there will be considerable uneasiness in the pharmaceutical and health insurance industries about imminent changes in 2021 and 2022.
Alzheimers is a devastating diagnosis for people suffering from the disease, as well as their families, but a group of researchers feels that they are one step closer to finding a cure.
The PsyTech Summit announces Rick Doblin, Founder and Executive Director of MAPS will be the Keynote Speaker at the inaugural Psychedelic Science, Innovation & Investment Conference in Israel Tel Aviv, Israel.
For now, the only prevention lies in avoiding tick contact but one company, Valneva, is working fervently to develop what they believe will be the world’s first vaccine against Lyme’s disease.
It has been no secret that the anti-vaxxer movement found a stronghold in the US in recent years with deadly repercussions. California is working to buck the trend.